Ilyang Pharmaceutical, 4Q Operating Profit 3.8 Billion KRW... Up 1577% YoY
[Asia Economy Reporter Hwang Yoon-joo] Ilyang Pharmaceutical announced on the 7th that its operating profit on an individual basis for the fourth quarter of last year increased by 1577% compared to the same period of the previous year, reaching 3.841 billion KRW. During the same period, sales increased by 28.3% to 64.733 billion KRW, and net profit turned positive to 2.332 billion KRW.
Hot Picks Today
!["It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
